Physician profile
Ryan P Garrow
NPI 1679037980
$659.24
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $179 · 2023: $222 · 2024: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $226.50 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $152.09 | 2021-2024 | Onyx Frontier |
| Becton, Dickinson and Company | $62.95 | 2024 | |
| Cardiovascular Systems INC. | $62.15 | 2021-2022 | |
| Boston Scientific Corporation | $33.71 | 2022-2023 | Synergy |
| Angiodynamics, INC. | $31.80 | 2023 | Alphavac |
| Abbott Laboratories | $21.72 | 2021 | |
| Cordis US Corp. | $19.31 | 2023 | Mynx Control |
| Terumo Medical Corporation | $16.78 | 2023 | Angio-Seal, Tr Band, Metacross Otw |
| Merck Sharp & Dohme LLC | $16.27 | 2023 | Verquvo |
| Chiesi USA, INC. | $15.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Garrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.